Clinical Trials Browser

Withdrawn × Interventional × Clear all

NCT05909527 2026-03-17

A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06654050 2026-03-17

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Phase 2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT07217496 2026-03-17

N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer

Phase 1 Withdrawn

Carcinoma, Transitional Cell

NCT07342517 2026-03-17

RESCUE

Phase 3 Withdrawn

Neoplasms, Urologic Neoplasms

NCT07284953 2026-03-13

PuraBond

Phase NA Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04953312 2026-03-12

CALPRO

Phase NA Withdrawn

MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT06229392 2026-03-11

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms, Influenza, Human, Triple Negative Breast Neoplasms

NCT07137390 2026-03-11

A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT06240390 2026-03-09

Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain

Phase NA Withdrawn

Cancer Pain, Neoplasms, Pain

NCT06292975 2026-03-06

Exercise for Improving Radiotherapy Efficacy in Rectal Cancer

Phase NA Withdrawn

Motor Activity

NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Phase NA Withdrawn

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT07439432 2026-02-27

Stereotactic Guided Biopsy and Cryoablation

Phase NA Withdrawn

Breast Neoplasms

NCT06796049 2026-02-25

Behavioral Nudge in Colorectal Cancer Screening

Phase NA Withdrawn

Improving Fecal Immunochemical Test (FIT) Completion Rates

NCT05014295 2026-02-24

Patient Recall of Cancer Screening and Diagnosis

Phase NA Withdrawn

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05170828 2026-02-24

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Phase 1 Withdrawn

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06297629 2026-02-24

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation

Phase 2 Withdrawn

Allogeneic Stem Cell Transplantation

NCT06522373 2026-02-24

Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia

NCT03905941 2026-02-23

SHK002

Phase EARLY_PHASE1 Withdrawn

Polycystic Ovary Syndrome

NCT05566223 2026-02-23

CheckCell-2

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT06608940 2026-02-19

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Phase 1/2 Withdrawn

Gastrointestinal

Liver Neoplasms

NCT06829199 2026-02-19

MK-5890-003

Phase 2 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06217094 2026-02-18

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Phase 1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT06868238 2026-02-18

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

Phase 2 Withdrawn

Carcinoma, Intraductal, Noninfiltrating, Lymphedema

NCT03027986 2026-02-17

PROTOMEN

Phase NA Withdrawn

Prostatic Neoplasms, Urinary Incontinence

NCT05312372 2026-02-17

S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC

Phase 1/2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05487859 2026-02-17

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

Phase 2 Withdrawn

Kidney Neoplasms

NCT05799612 2026-02-13

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Phase 1 Withdrawn

Hemangiosarcoma

NCT06284460 2026-02-13

Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms

Phase 1/2 Withdrawn

Classical hematologyMyeloid

Anemia, Refractory, with Excess of Blasts, Myeloproliferative Disorders

NCT06585969 2026-02-12

DISCORDANT

Phase 3 Withdrawn

Breast Neoplasms

NCT05360745 2026-02-11

FOODPANC

Phase NA Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT05512260 2026-02-11

BESTa

Phase NA Withdrawn

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT06501989 2026-02-11

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT07323576 2026-02-09

INAVO-CRC

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT04273555 2026-02-06

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

Phase 1/2 Withdrawn

HER2-positive Breast Cancer

NCT05175092 2026-02-06

Living Donor Liver Transplantation for CRC Liver Metastases

Phase NA Withdrawn

Gastrointestinal

Liver Metastasis Colon Cancer

NCT05488626 2026-02-05

ARTIA-Lung

Phase NA Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT06098755 2026-02-04

The Sequestration of Holistic Stress Management Techniques for Adults

Phase NA Withdrawn

Classical hematologyHead & NeckOther

Brain Injuries, Traumatic, Occupational Stress, Anemia, Anemia, Sickle Cell, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Depression, Escape Reaction, Fatigue, Flatfoot, Hemorrhoids, Hypertension, Hyperthyroidism, Immunologic Deficiency Syndromes, Erectile Dysfunction, Leiomyoma, Lordosis, Masturbation, Migraine Disorders, Priapism, Sickle Cell Trait, Stress Disorders, Post-Traumatic, Sexual Dysfunctions, Psychological, Migraine with Aura

NCT07226102 2026-02-04

Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer

Phase NA Withdrawn

BreastGynecologic

Genital Neoplasms, Female, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05850663 2026-02-03

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Phase NA Withdrawn

GynecologicHead & Neck

Uterine Cervical Neoplasms, Head and Neck Neoplasms, Endometrial Neoplasms

NCT02554344 2026-01-30

Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)

Phase EARLY_PHASE1 Withdrawn

Uterine Cervical Dysplasia

NCT04285268 2026-01-30

Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 2 Withdrawn

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT06068881 2026-01-30

Mandolin

Phase 2 Withdrawn

Lymphoma, Follicular

NCT06012929 2026-01-26

A Study of ONC201 for Refractory Meningioma

Phase 2 Withdrawn

Meningioma

NCT05044312 2026-01-23

Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis

Phase NA Withdrawn

Gastrointestinal

Gastrointestinal Neoplasms

NCT05846724 2026-01-22

PULSAR

Phase 2 Withdrawn

Sarcoma, Kaposi

NCT06922825 2026-01-21

Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients

Phase EARLY_PHASE1 Withdrawn

Neoplasms

NCT06967987 2026-01-21

BEMAFLOT

Phase 2 Withdrawn

Adenocarcinoma

NCT06163664 2026-01-13

Role of ChatGPT in Vestibular Schwannoma Management

Phase NA Withdrawn

Neuroma, Acoustic

NCT06466798 2026-01-08

Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies

Phase 1 Withdrawn

Ependymoma, Medulloblastoma, Central Nervous System Neoplasms

NCT06545617 2026-01-07

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Phase 1/2 Withdrawn

Fallopian Tube Neoplasms